Johnson & Johnson Assets Held-for-sale, Current (Deprecated 2014-01-31)
Johnson & Johnson (JNJ) had Assets Held-for-sale, Current (Deprecated 2014-01-31) of $41.00 million as of 2014-12-28, per its 10-K filed 2015-02-24.
Discontinued › Balance Sheet › Assets › Asset, Held-for-Sale, Not Part of Disposal Group
us-gaap:AssetsHeldForSaleCurrent · last filed 2015-02-24
- 2014-12-28: Assets Held-for-sale, Current (Deprecated 2014-01-31) $41.00M.
- 2014-06-29: Assets Held-for-sale, Current (Deprecated 2014-01-31) $509.00M.
- 2014-03-30: Assets Held-for-sale, Current (Deprecated 2014-01-31) $532.00M.
| Period end | Assets Held-for-sale, Current (Deprecated 2014-01-31) |
|---|---|
| 2014-12-28 | $41.00M 10-K · filed 2015-02-24 |
| 2014-06-29 | $509.00M 10-Q · filed 2014-08-01 |
| 2014-03-30 | $532.00M 10-Q · filed 2014-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |